Personnel of the Faculty of Science
Help Center
Updating personal information, please contact
HRMHuman Resource Management
(8015) (siriporn.t@psu.ac.th)
Updating publication information, please contact RSResearch Support
(8079) (thanapat.s@psu.ac.th)
Asst. Prof. Dr.
Sumalee Obchoei
Assistant Professor
- sumalee.o@psu.ac.th
- 8270
- Biochemistry
- Division of Health and Applied Sciences
Education
Graduated Year
Degree
Country
2011
Ph.D. (Medical Biochemistry) Khonkaen University
Thailand
2006
B.Sc. (Medical technology) Khonkaen University
Thailand
Publication
From Scopus
Author ID: 35503734500
1
Sirisarn W., Mordmuang A., Sukpondma Y., Obchoei S., Saeheng S., 2025. Sequential Solvent Extraction of Caesalpinia pulcherrima Yellow Flowers Reveals Potent Antioxidant, Antimicrobial, and Anticancer Activities Against Various Human Cancer Cell Lines. Trends in Sciences 22(4) (cited 0 times)
2
Sathitruangsak C., Pattarapuntakul T., Kaewdech A., Thongkan T., Prisutkul A., Thongwatchara P., Sriplung H., Kongkamol C., Kanokwiroon K., Obchoei S., Sripongpun P., 2024. Impact of Clinical Characteristics and Treatment on Cholangiocarcinoma Prognosis in Southern Thailand. Cancer Medicine 13(24) (cited 0 times)
3
Kidoikhammouan S., Lert-Itthiporn W., Deenonpoe R., Saengboonmee C., Obchoei S., Wongkham S., Seubwai W., 2024. Targeting EGFR Activation to Overcome Gemcitabine Resistance in Cholangiocarcinoma. Anticancer Research 44(12): 5393-5404. (cited 1 times)
4
Pratummanee K., Kerdkumthong K., Roytrakul S., Tantimetta P., Runsaeng P., Saeheng S., Obchoei S., 2024. Knockdown of cullin 3 inhibits progressive phenotypes and increases chemosensitivity in cholangiocarcinoma cells. Molecular Medicine Reports 30(5) (cited 1 times)
5
Pantong W., Somsap O.A., Kamnate A., Ekchaweng K., Obchoei S., Saeheng S., 2024. Analyzing the Antibacterial, Anticancer, and Antioxidant Qualities of the Stink Bean (Parkia Speciosa) by Various Extraction Techniques. Trends in Sciences 21(9) (cited 1 times)
6
Kerdkumthong K., Roytrakul S., Songsurin K., Pratummanee K., Runsaeng P., Obchoei S., 2024. Proteomics and Bioinformatics Identify Drug-Resistant-Related Genes with Prognostic Potential in Cholangiocarcinoma. Biomolecules 14(8) (cited 2 times)
7
Kerdkumthong K., Nanarong S., Roytrakul S., Pitakpornpreecha T., Tantimetta P., Runsaeng P., Obchoei S., 2024. Quantitative proteomics analysis reveals possible anticancer mechanisms of 5’-deoxy-5’-methylthioadenosine in cholangiocarcinoma cells. PLoS ONE 19(6 June) (cited 1 times)
8
Kerdkumthong K., Chanket W., Runsaeng P., Nanarong S., Songsurin K., Tantimetta P., Angsuthanasombat C., Aroonkesorn A., Obchoei S., 2024. Two Recombinant Bacteriocins, Rhamnosin and Lysostaphin, Show Synergistic Anticancer Activity Against Gemcitabine-Resistant Cholangiocarcinoma Cell Lines. Probiotics and Antimicrobial Proteins 16(3): 713-725. (cited 4 times)
9
Saengboonmee C., Obchoei S., Sawanyawisuth K., Wongkham S., 2023. Revision of potential prognostic markers of cholangiocarcinoma for clinical practice. Expert Review of Anticancer Therapy 23(5): 517-530. (cited 2 times)
10
Madsari N., Maskaew S., Obchoei S., Kwankaew P., Senghoi W., Utarabhand P., Runsaeng P., 2022. Determination of the efficacy of using a serine protease gene as a DNA vaccine to protect against Vibrio parahaemolyticus infection in Litopenaeus vannamei. Developmental and Comparative Immunology 135 (cited 4 times)
Content provided by Scopus.
Publication
From the Faculty of Science
1
Kidoikhammouan, S., Lert-itthiporn, W., Deenonpoe, R., Saengboonmee, C., Obchoei, S., Wongkham, S., & Seubwai, W. (2024). Targeting EGFR Activation to Overcome Gemcitabine Resistance in Cholangiocarcinoma. Anticancer Research, 44(12), 5393-5404.
2
Kerdkumthong , K., Chanket , W., Runsaeng, P., Nanarong , S., Songsurin , K., Tantimetta , P., Angsuthanasombat , C., Aroonkesorn, A., & Obchoei, S. (2024). Two Recombinant Bacteriocins, Rhamnosin and Lysostaphin, Show Synergistic Anticancer Activity Against Gemcitabine-Resistant Cholangiocarcinoma Cell Lines. Probiotics And Antimicrobial Proteins, 16(3), 713-725.
3
Sathitruangsak, C., Pattarapuntakul, T., Kaewdech, A., Thongkan, T., Prisutkul, A., Thongwatchara, P., Sriplung, H., Kongkamol, C., Kanokwiroon, K., Obchoei, S., & Sripongpun, P. (2024). Impact of Clinical Characteristics and Treatment on Cholangiocarcinoma Prognosis in Southern Thailand (SCIE). Cancer Medicine, 13(24), Article number e70491.
4
Pantong, W., Somsap, O., Ekchaweng, K., Obchoei, S., & Saeheng, S. (2024). Analyzing the Antibacterial, Anticancer, and Antioxidant Qualities of the Stink Bean (Parkia Speciosa) by Various Extraction Techniques. Trends In Sciences, 21(9), Article number 7994.
5
Kerdkumthong, K., Roytrakul, S., Songsurin, K., & Obchoei, S. (2024). Proteomics and Bioinformatics Identify Drug-Resistant-Related Genes with Prognostic Potential in Cholangiocarcinoma (SCIE). Biomolecules, 14(8), Biomolecules.
6
Pratummanee, K., Kerdkumthong, K., Roytrakul, S., Tantimetta, P., Runsaeng, P., Saeheng, S., & Obchoei, S. (2024). Knockdown of cullin 3 inhibits progressive phenotypes and increases chemosensitivity in cholangiocarcinoma cells (SCIE). Molecular Medicine Reports, 30(5), Article number 198.
7
Kerdkumthong, K., Nanarong, S., Roytrakul, S., Pitakpornpreecha, T., Tantimetta, P., Runsaeng, P., & Obchoei, S. (2024). Quantitative proteomics analysis reveals possible anticancer mechanisms of 5’-deoxy-5’-methylthioadenosine in cholangiocarcinoma cells (SCIE). Plos One, 19(6), Article number e0306060.
8
Kerdkumthong, K., Chanket, W., Runsaeng, P., Nanarong, S., Songsurin, K., Tantimetta, P., Angsuthanasombat, C., Aroonkesorn, A., & Obchoei, S. (2023). Two Recombinant Bacteriocins, Rhamnosin and Lysostaphin, Show Synergistic Anticancer Activity Against Gemcitabine-Resistant Cholangiocarcinoma Cell Lines (SCIE). Probiotics And Antimicrobial Proteins, 00, 00.
9
Saengboonmee, C., Obchoei, S., Sawanyawisuth, K., & Wongkham, S. (2023). Revision of potential prognostic markers of cholangiocarcinoma for clinical practice (SCIE). Expert Review Of Anticancer Therapy, 23(5), 517-530.
10
Obchoei, S., Detarya, M., Boonnate, P., Saranaruk, P., Vaeteewoottacharn, K., Mahalapbutr, P., Okada, S., & Wongkham, S. (2022). Low Dose Berberine Suppresses Cholangiocarcinoma Cell Progression as a Multi-Kinase Inhibitor. Asian Pacific Journal Of Cancer Prevention : Apjcp, 23(10), 3379 - 3386.
11
Madsari, N., Maskaew, S., Obchoei, S., Kwankaew, P., Senghoi, W., Utarabhand, P., & Runsaeng, P. (2022). Determination of the efficacy of using a serine protease gene as a DNA vaccine to protect against Vibrio parahaemolyticus infection in Litopenaeus vannamei (SCIE)
. Developmental And Comparative Immunology, 135, Article number 104459.
12
U Kotepui, K., Obchoei, S., Vaeteewoottacharn, K., Okada, S., Wongkham, S., & Sawanyawisuth, K. (2022). Annexin A1 Is a Potential Prognostic Marker for, and Enhances the Metastasis of, Cholangiocarcinoma. Asian Pacific Journal Of Cancer Prevention, 23(2), 715 - 721.
13
Klinhom-on, N., Seubwai, W., Sawanyawisuth, K., Obchoei, S., Mahalapbutr, P., & Wongkham, S. (2021). FOXM1 inhibitor, Siomycin A, synergizes and restores 5-FU cytotoxicity in human cholangiocarcinoma cell lines via targeting thymidylate synthase (SCIE). Life Sciences, 286, Article number 120072.
14
Dana, P., Saisomboon, S., Kariya, R., Okada, S., Obchoei, S., Sawanyawisuth, K., Wongkham, C., Pairojkul, C., Wongkham, S., & Vaeteewoottacharn, K. (2020). CD147 Augmented Monocarboxylate transporter-1/4 Expression Through Modulation of the Akt-FoxO3-NF-κB Pathway Promotes Cholangiocarcinoma Migration and Invasion. Cellular Oncology, 43(2), 211-222.